Riskpilot← Back to searchSign inGet full access2M Medical AB
ABActiveOrg 5590860606Movägen 13Medical specialists activities · NACE 8622Est. 20160 employees
Revenue 2024
SEK 1,7M
+475% vs 2023
EBITDA margin
46.9%
+3617% vs 2023
Equity ratio
82.5%
Financial strength
Net profit 2024
SEK 786K
+2024% vs 2023
| Revenue | SEK 1,7M | +475% |
| EBITDA | SEK 809K | +3617% |
| Net profit | SEK 786K | +2024% |
| Total assets | SEK 6,6M | +33% |
| Equity | SEK 5,5M | +12% |
| Employees | 0 | — |
Legal name
2M Medical AB
Org number
5590860606
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 november 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bemanning inom hälso-sjukvård samt privat sjukvård och estetisk kirurgi. Konsultation och rådgivning för medicinsk bedömning samt utlåtande och intyg. Särskilda intyg. Företagshälsovård. Vaccination och resemedicin.
Address
Movägen 13
Email
entbob@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 272 | 2 439 | 300 | 1 724 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −59 | 218 | 649 | −23 | 809 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −59 | 218 | 649 | −23 | 809 |
| Net financials | — | −5 264 | 10 | 105 | 356 |
| Profit before tax | 41 | −35 | 658 | 83 | 935 |
| Tax | −12 | −19 | −660 | −46 | −149 |
| Net profit | 29 | −54 | −2 | 37 | 786 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 742 | 7 900 | 8 800 | 4 977 | 6 625 |
| Equity | 5 446 | 5 212 | 5 030 | 4 877 | 5 467 |
| Long-term debt | 0 | 2 632 | 2 632 | 0 | 0 |
| Short-term debt | 916 | 56 | 1 138 | 100 | 928 |
| Total debt | 916 | 2 688 | 3 770 | 100 | 928 |
EBITDA margin
46.9%
This company
15.8%
Market median
+197% vs market
20202024
Equity ratio
82.5%
This company
38.2%
Market median
+116% vs market
20202024
Return on equity
14.4%
This company
18.4%
Market median
+22% vs market
20202024
Net profit margin
45.6%
This company
8.1%
Market median
+463% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CC Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
SL Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of 2M Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christine Chiu-Ping Huang | Chief Executive Officer | 0 companies |
| Steen Löth | Deputy Chief Executive Officer | 0 companies |
| Mathias You-Kai Chang | Deputy Board Member | 0 companies |
| Marcus You-Rong Chang | Board of Directors | 0 companies |